A letter from HHS Secretary Robert F Kennedy Jr. and FDA Commissioner Martin Makary, in which they confirmed that the FDA is ...

The drug – which will be sold in the US under the Inluriyo trade name – is only the second drug in the oral SERD category to ...

After all the threats, it seems President Trump's tariffs on pharmaceuticals are coming to fruition, and a lot sooner than ...

All of the DTC channels offer discounts for people willing and able to pay for medicines with cash, and that also applies to Sotyktu (deucravacitinib), which, from January, will be available at a ...

Investors in Verona – a specialist in respiratory medicines – overwhelmingly gave their blessing to MSD's $107-per-share ...

The San Diego-based company claims a number of firsts for its coin-sized Biolinq Shine device, including that it is so far ...

Merck KGaA's chief executive Belén Garijo will end her time at the helm of the company next April, five years after taking ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy ...

Under the Inflation Reduction Act of 2022, the Department of Health and Human Services (HHS), which oversees Medicare, can ...

Earlier this year, PTC Therapeutics and Novartis' experimental therapy for Huntington's, mRNA splicing modifier PTC518 ...

The Moderna Innovation and Technology Centre (MITC) in Harwell is the flagship part of a 10-year, £1 billion investment in ...

For more information about Axtria, please visit: www.axtria.com ...